Screening for More than 1,000 Pesticides and Environmental Contaminants in Cannabis by GC/Q-TOF
Medical Cannabis and Cannabinoids · 09.01.2020 · 3 (1) · 14-24
DOI: 10.1159/000504391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Cannabis and Cannabinoids, online erschienen am 09.01.2020. Verfasst von Philip L Wylie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Agilent Technologies, Wilmington, Delaware, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A method has been developed to screen cannabis extracts for more than 1,000 pesticides and environmental pollutants using a gas chromatograph coupled to a high-resolution accurate mass quadrupole time-of-flight mass spectrometer (GC/Q-TOF). An extraction procedure was developed using acetonitrile with solid phase extraction cleanup. Before analysis, extracts were diluted 125:1 with solvent. Two data mining approaches were used together with a retention-time-locked Personal Compound Database and Library (PCDL) containing high-resolution accurate mass spectra for pesticides and other environmental pollutants. (1) A Find-by-Fragments (FbF) software tool extracts several characteristic exact mass ions within a small retention time window where the compound elutes. For each compound in the PCDL, the software evaluates the peak shape and retention time of each ion as well as the monoisotopic exact mass, ion ratios, and other factors to decide if the compound is present or not. (2) A separate approach used Unknowns Analysis (UA) software with a peak-finding algorithm called SureMass to deconvolute peaks in the chromatogram. The accurate mass spectra were searched against the PCDL using spectral matching and retention time as filters. A subset PCDL was generated containing only pesticides that are most likely to be found on foods in the US. With about 250 compounds in the smaller PCDL, there were fewer hits for non-pesticides, and data review was much faster. Organically grown cannabis was used for method development. Twenty-one confiscated cannabis samples were analyzed and ten were found to have no detectable pesticides. The remaining 11 samples had at least one pesticide and one sample had seven detectable residues. Quantitative analysis was run on the confiscated samples for a subset of the pesticides found by screening. Two cannabis samples had residues of carbaryl and malathion that were estimated to be about 10 times greater than the highest US Environmental Protection Agency tolerance set for food and about 4,000 times greater than the Canadian maximum residue limits for dried cannabis flower.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Agilent Technologies, Wilmington, Delaware, USA.
- National Center for Natural Products Research, School of Pharmacy University of Mississippi, University, Mississippi, USA.
- Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, USA.
- ElSohly Laboratories Inc., Oxford, Mississippi, USA.
Zitieren
APA
Wylie, P. L., Westland, J., Wang, M., Radwan, M. M., Majumdar, C. G., & ElSohly, M. A. (2020). Screening for More than 1,000 Pesticides and Environmental Contaminants in Cannabis by GC/Q-TOF. Medical Cannabis and Cannabinoids, 3(1), 14-24. https://doi.org/10.1159/000504391
Vancouver
Wylie PL, Westland J, Wang M, Radwan MM, Majumdar CG, ElSohly MA. Screening for More than 1,000 Pesticides and Environmental Contaminants in Cannabis by GC/Q-TOF. Medical Cannabis and Cannabinoids. 2020;3(1):14-24. doi:10.1159/000504391
BibTeX
@article{Wylie2020,
author = {Wylie, Philip L and Westland, Jessica and Wang, Mei and Radwan, Mohamed M and Majumdar, Chandrani G and ElSohly, Mahmoud A},
title = {Screening for More than 1,000 Pesticides and Environmental Contaminants in Cannabis by GC/Q-TOF},
journal = {Medical Cannabis and Cannabinoids},
year = {2020},
volume = {3},
number = {1},
pages = {14--24},
doi = {10.1159/000504391}
}
EUVIMED